Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ada M Tata

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Recent Patents on CNS Drug Discovery|November 22, 2014
Pharmacological approaches to targeting muscarinic acetylcholine receptorsCarlo Matera, Ada M Tata
Recent Patents on CNS Drug Discovery|April 20, 2013
New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitorsNigel H Greig, Marcella Reale, Ada M Tata
CNS & Neurological Disorders Drug Targets|September 18, 2014
Cholinergic system dysfunction and neurodegenerative diseases: cause or effect?Ada M Tata, Lucia Velluto, Chiara D'Angelo, et al.
Plos One|September 10, 2020
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtypeAlejandro J Español, Agustina Salem, María Di Bari, et al.
The European Journal of Neuroscience|August 26, 2018
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phaseGiovanni Di Pinto, Maria Di Bari, Rocío Martin-Alvarez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Recent Patents on CNS Drug Discovery|November 22, 2014
Pharmacological approaches to targeting muscarinic acetylcholine receptorsCarlo Matera, Ada M Tata
Recent Patents on CNS Drug Discovery|April 20, 2013
New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitorsNigel H Greig, Marcella Reale, Ada M Tata
CNS & Neurological Disorders Drug Targets|September 18, 2014
Cholinergic system dysfunction and neurodegenerative diseases: cause or effect?Ada M Tata, Lucia Velluto, Chiara D'Angelo, et al.
Plos One|September 10, 2020
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtypeAlejandro J Español, Agustina Salem, María Di Bari, et al.
The European Journal of Neuroscience|August 26, 2018
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phaseGiovanni Di Pinto, Maria Di Bari, Rocío Martin-Alvarez, et al.
Pageof 1